Annual report pursuant to Section 13 and 15(d)

Cash Equivalents and Marketable Securities

v3.20.4
Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2020
Cash And Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities

4. Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following:

 

 

 

December 31, 2020

 

 

 

Amortized

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair

Value

 

 

 

(in thousands)

 

Money market funds

 

$

204,632

 

 

$

-

 

 

$

-

 

 

$

204,632

 

Commercial paper

 

 

42,208

 

 

 

-

 

 

 

-

 

 

 

42,208

 

Corporate debt securities

 

 

25,669

 

 

 

48

 

 

 

(1

)

 

 

25,716

 

Asset-based securities

 

 

12,593

 

 

 

39

 

 

 

-

 

 

 

12,632

 

U.S. government securities

 

 

39,743

 

 

 

44

 

 

 

(2

)

 

 

39,785

 

Total

 

 

324,845

 

 

 

131

 

 

 

(3

)

 

 

324,973

 

Less amounts classified as cash equivalents

 

 

(204,632

)

 

 

-

 

 

 

-

 

 

 

(204,632

)

Total marketable securities

 

$

120,213

 

 

$

131

 

 

$

(3

)

 

$

120,341

 

 

 

 

December 31, 2019

 

 

 

Amortized

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair

Value

 

 

 

(in thousands)

 

Money market funds

 

$

3,151

 

 

$

-

 

 

$

-

 

 

$

3,151

 

Commercial paper

 

 

4,952

 

 

 

-

 

 

 

-

 

 

 

4,952

 

Corporate debt securities

 

 

69,423

 

 

 

79

 

 

 

(3

)

 

 

69,499

 

Asset-based securities

 

 

27,005

 

 

 

50

 

 

 

-

 

 

 

27,055

 

U.S. government agencies

 

 

26,968

 

 

 

39

 

 

 

-

 

 

 

27,007

 

Total

 

 

131,499

 

 

 

168

 

 

 

(3

)

 

 

131,664

 

Less amounts classified as cash equivalents

 

 

(3,151

)

 

 

-

 

 

 

-

 

 

 

(3,151

)

Total marketable securities

 

$

128,348

 

 

$

168

 

 

$

(3

)

 

$

128,513

 

 

As of December 31, 2020 and 2019, zero and $15.6 million, respectively, of marketable securities had maturities of more than one year and are classified as long-term assets.  

As of December 31, 2020, there was $14.7 million of investments in an unrealized loss position, with a total unrealized loss of $3,000 associated with these investments. As of December 31, 2019, there was $4.5 million of investments in an unrealized loss position, with a total unrealized loss of $3,000 associated with these investments. During the years ended December 31, 2020 and 2019 the Company did not record any other-than-temporary impairment charges on its available-for-sale securities. Based upon the Company’s impairment review, the Company determined that the unrealized losses were not attributed to credit risk but were primarily associated with changes in interest rates. Based on the scheduled maturities of the investments, the Company was more likely than not to hold these investments for a period of time sufficient for a recovery of the Company’s cost basis.  As such, the Company concluded that the unrealized losses in the investment securities were not other-than-temporary.